Patients with specific variants in RYR1 or genes encoding RyR1-associated proteins that make the SR leaky to Ca2+ are at risk of developing malignant hyperthermia (MH) under anesthesia in which volatile anesthetics trigger uncontrolled Ca2+ release and heat production (3). The gene discussed is RYR1; the disease is Malignant hyperthermia.